The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin | MicrobiomeTrials← Back to trialsNCT06223685
The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin
CompletedNAINTERVENTIONAL
Trial Details
Start: 2023-04-01Est. Completion: 2024-08-01
Enrollment target: 129 participants Locations- Sonomed CENTRUM MEDYCZNE, Szczecin, West Pomeranian Voivodeship, Poland
Other microbiome trials you might be interested in
Functional Gastrointestinal Disorders (FGID)
Brief Summary
Functional gastrointestinal disorders (FGID), including irritable bowel syndrome (IBS), are common condit…
Multiple LocationsEst. completion Sep 1, 2027
Irritable Bowel Syndrome (IBS)
To explore the efficacy of pregabalin for patients with irritable bowel syndrome (IBS).
Beijing, ChinaEst. completion Apr 8, 2026
Ulcerative Colitis
Healthy
Irritable Bowel Syndrome With Diarrhea
This trial is being completed to learn about how Aquamin® affects gastrointestinal permeability, or the control of mater…
Ann Arbor, United StatesCompleted Mar 11, 2024